Topics & News
-
open_in_new NEWABE & PARTNERS represented Bayer Healthcare against Samsung Bioepis in an Unfair Competition PI Case and received a dismissal decision.
-
NEWGerman Law & Patent Firm has visited ABE & PARTNERS.
-
NEWUK Law Firm has visited ABE & PARTNERS.
-
open_in_newTakanori ABE gave a speech at AIPPI Pharma Webinar "What Discovery Mechanisms Exist in China, Japan, Korea, and India to Aid in the Preparation of a Preliminary Injunction (PI) Request or General Evidence Gathering?".
-
NEWUS Law Firm has visited ABE & PARTNERS.
-
NEWABE & PARTNERS represented U.S. Pharmaceutical Company against X in Patent Opposition and received a decision to maintain the patent.
-
Takanori ABE gave a speech regarding Japanese pharmaceutical patent litigation at the client company (a pharmaceutical company, listed on the Prime Market of Tokyo Stock Exchange).
-
Takanori ABE gave a lecture entitled "How was Japanese patent litigation reformed" at Japan-China IP Conference organized by JAPIT.
-
open_in_new NEWTakanori ABE's article titled "Patent royalty claim dismissed due to a demurrer, admitting the reach of an arbitration agreement - Defendants' measures and plaintiffs? risk reduction -" had been published on Japan Commercial Arbitration Journal Vol. 5 [2024].
-
Chinese Law Firm has visted ABE & PARTNERS.
-
NEWABE & PARTNERS represented Japanese Pharmaceutical Company against Indian Pharmaceutical Company in the Trial for Patent Invalidation for vaccine patent case and received invalidity decision.
-
Takanori ABE's comment appeared in an article titled "Avoiding disputes between university and industry, patent agreements are critical" in Yomiuri Newspaper.
-
Takanori ABE has been selected as IP Star 2024 by Managing Intellectual Property.
-
Takanori ABE gave a lecture entitled "Medical Standard of Care" at Faculty of Medicine, Osaka University.
-
open_in_newABE & PARTNERS has been ranked Tier2 in Japan Domestic, Patents by Asian Legal Business' ALB 2024 IP Ranking.
-
open_in_newTakanori ABE's interviewed article titled "Five minutes with…Takanori Abe, Abe & Partners" had been published on Managing Intellectual Property.
-
Singaporean Law Firm has visited ABE & PARTNERS.
-
Takanori ABE published the article titled "Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism".
-
open_in_newTakanori ABE's article titled "Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism" had been published on LSIPR.
-
German Law & Patent Firm has visited ABE & PARTNERS.
-
open_in_newTakanori ABE has been selected as Top 50 IP Experts of Japan 2024 by Asia IP.
-
open_in_newTakanori ABE gave a speech entitled "Amgen v. Sanofi/Regeneron in Japan" at the session "Amgen vs Sanofi/Regeneron” at Pharma & Biotech Patent Litigation Summit, Europe.
-
Takanori ABE published the article titled "Preliminary injunctions in pharmaceutical patent cases in Japan".
-
open_in_newTakanori ABE's article titled "Preliminary injunctions in pharmaceutical patent cases in Japan" had been published on LSIPR.
-
open_in_newTakanori ABE gave a speech entitled "Japan, Pharma and Biotech Patent Litigation Case Law Review" at Pharma & Biotech Patent Litigation Summit, Europe.
-
Our firm member enjoyed a tour of the Ijinkan (former foreign residences) in Kobe and held a year-end party.
-
UK Law Firm has visited ABE & PARTNERS.
-
UK Patent Firm has visited ABE & PARTNERS.
-
UK Law & Patent Firm has visited ABE & PARTNERS.
-
German Law & Patent Firm has visited ABE & PARTNERS.
-
German Law & Patent Firm has visited ABE & PARTNERS.
-
Takanori ABE has been selected as IP Star 2023 by Managing Intellectual Property.
-
Takanori ABE gave a speech entitled "Issues with the re-examination system having both a function of ensuring the safety of medicinal products and a function of data protection - The necessity to redesign the re-examination system from both pharmaceutical and IP perspectives -" at the client company (a pharmaceutical company, listed on the Prime Market of Tokyo Stock Exchange).
-
open_in_newTakanori ABE gave a speech entitled "Experimental use exception (Bolar) in Japan" at the session "The Bolar Exemption and Safe Harbor" at Life Sciences Strategy Summit on IP & Exclusivity.
-
Takanori ABE's article titled "Patent royalty claim dismissed due to a demurrer, admitting the reach of an arbitration agreement" had been published on JCA Journal.
-
open_in_newTakanori ABE gave a speech entitled "Patent Term Extensions in Japan" at the session "Global Patent Term Extension Update" at Life Sciences Strategy Summit on IP & Exclusivity.
-
Takanori ABE's published the article titled "Issues with the re-examination system having both a function of ensuring the safety of medicinal products and a function of data protection - The necessity to redesign the re-examination system from both pharmaceutical and IP perspectives -".
-
open_in_newTakanori ABE gave a speech entitled "Experimental use exception (Bolar) in Japan" at the session "Spotlight on the Bolar Exemption" at Life Sciences IP Summit.
-
open_in_newTakanori ABE gave a speech entitled "Patent Term Extensions in Japan" at the session "Patent Term Extension Master Class" at Life Sciences IP Summit.
-
Takanori ABE gave a speech entitled "5G in Japan" at 5G Webinar_Who is Leading the 5G Patent Race - Asia.
-
Takanori ABE co-authored an article with a medical doctor entitled "Treatment of germ cell tumor and medical liability".
-
open_in_newTakanori ABE conducted as a moderator at a session titled "FRAND/SEP regulation across the globe" at IAM Connect SEP Summit.
-
open_in_newTakanori ABE's article titled "Regimen patents in Japan: LCM failures and successes" had been published on LSIPR.
-
Takanori ABE published the article titled "Regimen patents: LCM failures and successes".
-
Takanori ABE's article titled "Generic should sue the Minister of Health, Labour and Welfare instead of filing a DJ action, says IP High Court" had been published on Managing Intellectual Property.
-
Takanori ABE published the article titled "Generic should sue the Minister of Health, Labour and Welfare instead of filing a DJ action, says IP High Court".
-
Takanori ABE gave a speech entitled "Standard Essential Patents: Judgments, Guidelines, the automotive industry in Japan. Connected Cars and Patent Litigation." at KTK.
-
Takanori ABE gave a speech entitled "Standard Essential Patents: Judgments, Guidelines, the automotive industry in Japan. Connected Cars and Patent Litigation." at the Osaka Institute of Invention and Innovation.
-
open_in_newTakanori ABE's comment appeared in an article titled "Hydrogen patents shift to clean technologies" in Asia IP.
-
open_in_newTakanori ABE gave a speech entitled "Patenting Regimen and effect on LCM-analyzing failures and successes in LCM-" at Technical Information Institute.
Archive